Introduction: Endometriosis is associated with an increased risk of dyspareunia, therefore this chronic gynaecologic disease should be considered as a major cause of sexual dysfunctions.
Introduction
Sexual functioning is an important dimension that impacts on women's physical and psychological health, and quality of life (1) . Female sexual functioning can be negatively affected by a variety of factors, such as operative vaginal delivery (2) and life stressors related to medical illness, including infertility (1, 3) . Among these stressors, endometriosisa chronic gynaecological disease characterized by the presence of endometrial glands and stroma outside the uterine cavity-is associated with a ninefold increased risk of dyspareunia relative to the general female population (4, 5) . Deep dyspareunia (i.e., pain experienced inside the vaginal canal, at the level of the cervix, or in the pelvic/uterine/abdominal region, associated with sexual intercourse) caused by endometriosis has been frequently linked to specific types of lesions, such as those infiltrating the uterosacral ligaments, the pouch of Douglas, the posterior vaginal fornix and the anterior rectal wall (1) . Pain during intercourse can be triggered by traction of scarred and anelastic endometriotic tissue or by mechanical pressure on lesions occurring during coitus (1) . Dyspareunia is also associated with other forms of sexual dysfunctions, such as hypoactive sexual desire, decreased lubrication, arousal difficulties, and orgasm disorders due for instance to fear and anticipation of pain, which represents one of the most powerful inhibitor of the sexual response cycle (6) (7) (8) . Several
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This article is protected by copyright. All rights reserved. studies have demonstrated the association between pain at intercourse and anxiety, lower frequency or even avoidance of intercourse, lower levels of desire and arousal, and poorer orgasm (9) (10) (11) , with negative effects on women's physical and psychological wellbeing, as well as on the couple relationship.
Research investigating the association between endometriosis and global female sexual functioning has outlined an even more complex clinical scenario, suggesting that dyspareunia is not the unique sexual problem associated with the disease. It was estimated that around two thirds of women with endometriosis suffer from some type of sexual dysfunction, such as pain at intercourse, low satisfaction, lack of desire, low arousal, orgasm difficulties, with a negative impact on women's psychological health and intimate relationships (8, (12) (13) (14) . Because endometriosis affects from 5% to 10% of women of reproductive age (15) , it is imaginable that a large proportion of young women in their most sexually active period of life present sexual dysfunction caused by the disease, which may interfere with conception (5) . For this reason, dyspareunia and sexual dysfunctions associated with endometriosis represent a major clinical problem as well as an important outcome of endometriosis treatments. However, to our knowledge, there are no published review articles on the effects of surgical and pharmacological treatments for endometriosis on female sexual functioning.
The aims of the current systematic review are: 1) to describe and compare the effectiveness of surgical and pharmacological endometriosis treatments in relation to female sexual functioning; 2) to provide suggestions for treatment strategies based on research evidence.
Material and methods
The present review was conducted according to the PRISMA guidelines for systematic reviews (16) and we ensured compliance by completing the PRISMA checklist.
We further assessed the quality of evidence of the selected studies using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria (17) . Since only published data were used, the present study was exempt from Institutional Review Board approval.
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Sources
An electronic database search (PubMed, Medline) was conducted to identify all English-language journal articles published between January 2000 and January 2016 on the impact of endometriosis treatments on female sexual functioning. Appropriate search terms were constructed by reviewing titles, abstracts, and key-words of a sample of articles investigating sexual dysfunctions in patients with endometriosis. Combinations of subject heading terms including 'endometriosis', 'rectovaginal endometriosis', 'deep infiltrating endometriosis', 'sexuality', 'sexual function', 'sexual dysfunction', 'dyspareunia', and 'sexual life' were used. All pertinent papers were retrieved and their reference lists were systematically examined to identify additional articles. No attempt was made to identify unpublished studies.
Study selection and data extraction
The present review was designed to provide an overview on the effects of endometriosis surgical and pharmacological treatments on female sexual functioning; thus, all published studies evaluating the impact of endometriosis treatments on sexual outcomes were included, without any specific restriction regarding the type of endometriotic lesion and medical intervention. Two authors (G.B. and F.F) conducted an independent screening of all titles and abstracts retrieved from peer-reviewed journals to exclude irrelevant or duplicate citations. Because of the paucity of randomized controlled trials (RCTs) on the sexual effects of medical interventions in patients with endometriosis, we decided to include all selected observational and retrospective studies based on adequacy of description of participants, setting, surgical or pharmacological intervention conducted, and sexual outcomes. In order to investigate all aspects of female sexual functioning, we included only studies in which sexual outcomes were evaluated with a comprehensive sexual questionnaire, focusing not only on dyspareunia, but also on other aspects, such as frequency of intercourses, desire, arousal, lubrication, sexual satisfaction, orgasm. Exclusion criteria were: qualitative research, casereport, commentaries or review articles that did not include original data, measurement of dyspareunia as unique sexual outcome.
Two authors (G.B. and F.F.) designed a data extraction form that was applied to each paper to independently extract data in relation to author, year of publication, location, setting, study design, number of participants, type of endometriosis, sexual functioning questionnaire, type of surgical or pharmacological intervention, time to follow-up, principal aims, and
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outcomes. The quality of evidence of the included studies for the outcome of interest was assessed following the criteria described by the GRADE method (17. According to the GRADE criteria, the quality of evidence is divided into four categories: high, moderate, low, and very low.
Results
A total of 615 articles were identified by database search as potentially relevant. Of these 615 articles, 60 had titles or abstracts reporting findings related to the association between endometriosis and sexuality, as well as to the assessment of sexual functioning after pharmacological or surgical treatment of endometriosis. Overall, 38 articles were not included in the current review: 3 studies because the language used was not English (18) (19) (20) ; 11 because they were review articles or commentaries (5, 11, (21) (22) (23) (24) (25) (26) (27) (28) (29) ; 2 because they were qualitative studies (30-31); 14 because dyspareunia was the only sexual outcome evaluated, no comprehensive sexual questionnaires were used, or no specific information from the questionnaires used was reported (1, 32-44); 8 because they were studies on the impact of having endometriosis on sexual functioning, without considering the effect of any medical intervention (7, 8, (12) (13) (14) (45) (46) (47) . Complete author agreement (G.B. and F.F.) regarding included and excluded studies was achieved. 
Characteristics of studies
Substantial differences were found in methodology, population, and outcome measures of the studies included. The characteristics of the selected studies are extensively reported in Table 1 in relation to the following variables: author, year, country, study aims, study design, sample, type of endometriosis, sexual functioning measures, time to follow-up.
Overall, there were 16 prospective observational cohort studies (48-63 ), 2 retrospective cohort studies (64, 65), 2 RCT (66, 67), one patients' preference parallel cohort study (68) , and one before and after study (69) . The number of subjects with endometriosis enrolled in the studies ranged from 7 (50) to 250 (60) . The most used questionnaire evaluating sexual functioning was the Female Sexual Function Index (FSFI).
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Seventeen studies examined the effects of surgery for endometriosis on female sexual functioning (48-58, 60, 61, 63-65, 68) , whereas the impact of pharmacological therapy on sexual functioning was assessed in only 5 studies (59, 62, 66, 67, 69) . Four studies analysed the effects of combined surgical and post-operative pharmacological treatment on sexual functioning (52, 55, 60, 68) .
The main sexual outcomes of the studies included in the review are reported in Table   2 . The heterogeneity of the studies in relation to research methods, types of endometriosis, types of treatment, questionnaires used, and sexual outcomes considered did not allow to adopt a meta-analytic approach to summarize the results. Thus, we decided to classify the studies on the basis of the type of therapeutic intervention performed, so that two categories were identified: 1) surgical intervention and 2) pharmacological intervention studies.
Surgical intervention studies
We found 17 articles evaluating postoperative sexual outcomes of surgery for endometriosis (48-58, 60, 61, 63-65, 68) , which was performed at laparoscopy in most of these studies (48-55, 57, 60, 63, 64, 65) . Time to follow-up ranged from 4 (48) to 60 (49) 
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This article is protected by copyright. All rights reserved. up to 5 years after surgery. The majority of patients (74%) suffered from non-menstrual pelvic pain and only 3.5% from dyspareunia; 70% of patients had had one previous surgery.
Data on revised American Fertility Society (rAFS) stage of endometriosis were recorded during surgery (see Table 1 ); 6% of patients had a full thickness vaginal lesion and 88% of women had an involvement of the uterosacral ligaments. Women showed improved sexual functioning (pleasure and habit) and decreased discomfort with intercourse at 60 months after surgery, although the probability of requiring further surgery was 36%. 
This article is protected by copyright. All rights reserved. 
This article is protected by copyright. All rights reserved. were not randomly allocated, as the design of the study was a patient preference, parallel cohort study with a 12-month follow-up. Findings showed improved sexual function immediately after surgery, but the effect declined over time. A more gradual, but progressive increase was observed during progestin use and no significant between-group differences emerged at 12-month follow-up. The authors concluded that both surgery and low dose norethisterone acetate treatment can be considered as valuable strategies for reducing the negative effects of deep dyspareunia related to endometriosis on women's sexual functioning.
Taken together, the above mentioned studies showed that surgery for endometriosis may lead to improved sexual functioning, although the extent and the length of these positive effects were often poorly defined. Most articles had an exclusive focus on DIE and radical laparoscopic surgery (including bowel resection). Although several studies considered of a post-operative pharmacological adjuvant therapy, a comparison between surgery and hormonal treatment was systematically addressed only in one study (68) .
Pharmacological intervention studies
We found only 5 studies (59, 62, 66, 67, 69) 
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Discussion
The aims of the current review were to describe and compare the effectiveness of different treatments of endometriosis in relation to sexual functioning and to suggest useful treatment strategies based on research evidence, as well as new avenues for future studies. In our systematic review, we adopted a comprehensive approach as we considered multiple dimensions of female sexuality, and not just pain at intercourse. Such a wide-ranging perspective is consistent with the evidence provided by the research literature, which has shown that: a) reduction of pain at intercourse, though important, does not necessarily lead to
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improved overall sexual functioning (6); b) female sexual function is a multifactorial process that involves different psychological dimensions (e.g., personality traits, body image, selfesteem, relational adjustment) and sexual mechanisms (e.g., interest in sex, desire, arousal, pleasure, satisfaction with sex and with partner), which are pivotal for good sexuality.
Overall, the studies examined in this review highlighted that endometriosis, especially when associated with deep dyspareunia and/or chronic pelvic pain, has strong negative effects on several domains of female sexual functioning, such as desire, orgasm, satisfaction with sex, and frequency of sexual intercourses. Particular types of endometriotic lesions, such as DIE and rectovaginal endometriosis, are associated with the poorest sexual functioning, perhaps because the women affected suffer from deep dyspareunia more frequently than those who have other forms of endometriosis or healthy women (7, 12, 14) .
However, several authors (30, 70) have recently suggested that the assessment of dyspareunia itself does not allow for a comprehensive and precise evaluation of female sexual functioning. Although dyspareunia is perceived as very distressing by many women, there may be variability in the way it is experienced, as women may display different coping strategies. For example, some women may decide to avoid pain by limiting, or even avoiding, sexual intercourses; other women may try to find their own way to deal with the pain during sex (for instance, by changing position) for several reasons, such as the importance given to sexual intimacy, or the wish for a pregnancy (30) . Different coping strategies may lead to differences in the psychological impact of dyspareunia, for example as regards mental health, self-esteem, feelings of femininity, and sense of guilt toward the partner. These issues have been poorly investigated so far and future studies should examine the role of individual differences, especially in terms of personality traits and coping strategies, to reach broader understanding of sexual dysfunction associated with endometriosis. In this light, interdisciplinary research conducted by different cooperating professionals (such as gynaecologists, psychologists, and sexologists) may lead to increased knowledge, as well as to the development of effective treatment programmes.
Overall, research has shown that surgical and pharmacological interventions are both valuable options to ameliorate sexual outcomes in a medium-/long-term period in women with endometriosis, although the extent and the duration of the observed positive effects have been poorly defined. The reviewed articles focused more on surgical rather than
This article is protected by copyright. All rights reserved. pharmacological treatment, thus limited evidence is available on the efficacy of hormonal therapy on endometriosis-related sexual dysfunction. This paucity of data may be due to the fact that the types of endometriosis more frequently associated with sexual impairment (i.e., DIE and rectovaginal endometriosis) have been historically treated with surgery, although some authors have underlined that medical treatments other than surgery may lead to substantial relief of pain in women with these forms of endometriosis (23, 33, (70) (71) (72) (73) .
Overall, heterogeneity of population, instruments, and sexual outcomes considered did not allow to pool data and estimate the sexual effects of the interventions evaluated by the studies included in this review. However, some conclusions can be drawn from our analysis.
Surgical treatment may improve sexual functioning in women with endometriosis, irrespective of the type of surgery (standard surgical procedure at laparoscopy or laparotomy; radical, conservative, or nerve sparing surgery). Postoperative improvement in sexual functioning is presumably linked to cessation of pain, especially dyspareunia, due to the excision of endometriotic foci. Several studies (11, 14) have shown that this sexual benefit appears more evident when the endometriotic lesions are localized in the posterior pelvic 
Risks and benefits of any surgical procedure must always be considered and clearly explained to women in order to obtain a full informed consent. This is important if one considers that the expected advantages of surgery may influence women's choices. For example, expectations of pain relief, infertility resolution, or amelioration of sexual health may affect patients' decisions to undergo high risk elective surgery. Moreover, women should be informed that, unfortunately, the global effectiveness of surgical treatment of DIE is operator-dependent. Overall, in the absence of absolute medical indications, surgery can be considered as a good option to improve dyspareunia and global sexual functioning when hormonal treatment is not feasible (such as for women who are attempting spontaneous conception), or when estro-progestin or progestin treatment is ineffective, contraindicated or not tolerated because of side effects.
The evidences (although limited) provided by the studies on the efficacy of different hormonal treatments with respect to female sexual functioning suggest that pharmacological intervention could be a good option for women who are not seeking conception, or underwent multiple surgeries for endometriosis without long-lasting benefit, or refuse surgery due to potential complications. Further research is needed in order to investigate the role of hormonal therapy, as well as the effects of the various available compounds.
Overall, the generalizability of the results provided by the studies examined in this review is limited. In most studies evaluating surgical treatments, the presence of sexual dysfunction was not the reason for surgical intervention and sexual functioning was not the primary study outcome, which involves limitation in the external validity of the reported benefits. The population examined represents another limitation, since several studies included only women with deep dyspareunia, while other articles did not provide clear information about pain severity or types of endometriotic lesions. In several studies (52, 55, 60) women underwent a combined surgical and postoperative hormonal treatment, such that it was not possible to clearly identify the proportion of variance explained by surgery versus hormonal therapy. Furthermore, many studies did not report whether patients underwent a pre-or postoperative hormonal treatment, which entails partial understanding of the results.
More research is necessary to explore in-depth sexual functioning in women with endometriosis. Future studies should consider the impact of other dimensions, such as infertility, which significantly affects intimate relationships, as well as the role of the partner.
Conclusions
Sexual functioning is negatively affected by endometriosis, which means that a large proportion of women of reproductive age present sexual dysfunction. The research literature on endometriosis, as well as our own clinical practice, undoubtedly indicate that these young women very often do not have the chance to experience pleasure associated with sexual activity. Furthermore, the extant literature on the effects of surgical and pharmacological interventions for endometriosis suggests that medical treatment is indeed useful, but may not necessarily lead to long-term, definitive resolution of women's sexual problems.
Since sexual functioning is a multidimensional phenomenon deriving from the interaction of multiple physical/anatomical, psychosocial, and emotional factors (74) , and considering that endometriosis affects multiple physical and psychological dimensions (75), we think that the best treatment programme can be provided by multidisciplinary teams composed of gynaecologists, sexologists, and psychologists/psychotherapists. A more comprehensive perspective not exclusively focused on pain may help rule out sexual dysfunction in a more complete and precise manner, with subsequent identification of the most appropriate approach to treatment. As demonstrated by several studies (6) , different types of sexual dysfunction (such as pain during intercourse, hypoactive sexual desire disorder, lack of arousal, or lack of orgasm) require different treatment programmes. Therefore, comprehensive sexual health assessment should be routinely conducted with all women referring to dedicated endometriosis centres and the improvement of sexual functioning should be considered as a major therapeutic goal. Sexual questionnaires may be effectively used by all gynaecologists during preliminary assessment to outline women's sexological profile, as well as to facilitate patient expression of thoughts, feelings, complaints or questions regarding sexual life. This is particularly important if one considers that patients may feel embarrassed and therefore reluctant to express any type of feeling or concern regarding sexuality to their gynaecologists. At the same time, gynaecologists may be more likely to prioritise addressing other endometriosis-related issues, such as pelvic pain and its medical treatment, with a general lack of knowledge about sexual medicine that may not allow formulating appropriate questions to rule out sexual dysfunction and indicate adequate therapeutic options.
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We believe that gynaecological practice with endometriosis patients may be improved by providing gynaecologists with training in sexual medicine . If sexual dysfunction is ruled out during preliminary assessment, further investigation should be conducted by professionals specialized in sexual counselling and therapy focusing not only on the symptoms presented by the patient, but also on the association between sexual problems and other important psychological, relational, and cultural dimensions, such as for instance selfesteem, body image, quality of intimate relationship and dyadic coping strategies, and cultural beliefs about femininity and sexuality.
This article is protected by copyright. All rights reserved. Figure 1 . Study selection flow chart. Table 1 . Characteristics of studies included in systematic review of evaluation of sexual function after treatments for endometriosis. 
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This article is protected by copyright. All rights reserved. A significant improvement in sexual function was observed in both the cyproterone acetate arm and the oral contraceptive arm; there were no significant differences between the two groups. Abbott et al., 2003 (49) Laparoscopic excision of endometriosis // There is a significant improvement in pleasure and habit, and a decrease in discomfort with intercourse that is maintained up to 5 years..
Lyons et al, 2006 (50)
Fertility-paring laparoscopic surgery with bowel resection // Sexual outcomes improved 12 months after surgery, although measurements did not reach statistical significance Ferrero et al., 2007 (51) Complete laparoscopic excision of all visible endometriotic lesions // 12 months after surgery patients with endometriosis of the uterosacral ligaments reported increased variety in sex life, increased frequency of intercourse, more satisfying orgasms and being more relaxed and fulfilled after sex. Similar improvements were observed among women with endometriosis but no involvement of uterosacral ligaments; however for some variables statistical significance was not reached. Radical laser CO 2 // Sexual function improved significantly following surgery with respect to pleasure, discomfort
